-
Beyond palliative relief for severe dry eye disease
Thursday, December 3, 2020Clinical trial shows high molecular weight hyaluronic acid drops improve symptoms and regenerate damaged corneal nerves
-
Novel approach to keratoconus
Thursday, December 3, 2020New Bowman’s layer grafting technique shows promise
-
Cell therapy for Fuchs’ dystrophy
Thursday, December 3, 2020Bright future ahead for treatment of corneal endothelial dysfunction
-
Reconstructing the ocular surface
Thursday, December 3, 2020KPro can achieve good outcomes where standard keratoplasty is not appropriate
-
Corneal endothelial disease
Monday, November 16, 2020Endothelial cells treated with magnetic nanoparticles have been injected into humans to successfully treat corneal oedema
-
Options for limbal stem cell deficiency
Tuesday, November 3, 2020Recent advances in transplantation techniques and tissue engineering have greatly improved outcomes in limbal stem cell deficiency (LSCD) and other indications requiring ocular surface reconstruction
-
New dry eye diagnostic tools
Monday, November 2, 2020Ongoing research into the role that inflammation plays in the development and propagation of dry eye disease (DED) is opening compelling new avenues for the treatment of this complex disorder, says Marc Labetoulle MD, PhD.
-
DMEK in the real world
Monday, November 2, 2020Descemet’s membrane endothelial keratoplasty (DMEK) appears to offer the best option today for long-term graft survival for the management of endothelial dysfunction, but remains a challenging procedure
-
New approaches to dry eye disease
Sunday, November 1, 2020Clinicians now have multiple options at their disposal in the treatment of dry eye disease (DED), including topical over-the-counter medications and a growing range of devices that target Meibomian gland dysfunction
-
Phakic IOL endothelial risk
Friday, October 30, 2020Eyes implanted with any type of phakic intraocular lenses (IOLs) require follow-up visits to monitor for possible damage to the corneal endothelium,
